<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-STC-2279</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-2434</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МАТЕРИАЛЫ ФОРУМА "ДНИ ИММУНОЛОГИИ В СПБ" 2021</subject></subj-group></article-categories><title-group><article-title>ЦИТОКИНОВЫЙ ПРОФИЛЬ Th1/Th2/Th17 В ПЛАЗМЕ И ПОЛИМОРФИЗМ ГЕНОВ (IL12B, IL13, IL31, IL33) У БОЛЬНЫХ АСТМОЙ ДЕТЕЙ: МУЛЬТИПЛЕКСНЫЙ АНАЛИЗ</article-title><trans-title-group xml:lang="en"><trans-title>PLASMA Th1/Th2/Th17 CYTOKINE PROFILE AND CYTOKINE GENE POLYMORPHISMS (IL12B, IL13, IL31, IL33) IN ASTHMATIC CHILDREN: A MAGNETIC MULTIPLEX ASSAY</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смольникова</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Smolnikova</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.б.н., ведущий научный сотрудник, руководитель группы молекулярно-генетических исследований, </p><p>660022, г. Красноярск, ул. Партизана Железняка, 3г</p></bio><bio xml:lang="en"><p>PhD (Biology), Leading Research Associate, Head, Molecular Genetic Research Group,</p><p>660022, Krasnoyarsk, Partizan Zheleznyak str., 3g</p></bio><email xlink:type="simple">smarinv@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горбачева</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Gorbacheva</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>старший научный сотрудник, </p><p>660022, г. Красноярск, ул. Партизана Железняка, 3г</p></bio><bio xml:lang="en"><p>Senior Research Associate,</p><p>660022, Krasnoyarsk, Partizan Zheleznyak str., 3g</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шубина</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shubina</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>младший научный сотрудник,</p><p>660022, г. Красноярск, ул. Партизана Железняка, 3г</p></bio><bio xml:lang="en"><p>Junior Research Associate,</p><p>660022, Krasnoyarsk, Partizan Zheleznyak str., 3g</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Терещенко</surname><given-names>С. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Tereschenko</surname><given-names>S. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., профессор, заведующий клиническим отделением соматического и психического здоровья детей, </p><p>660022, г. Красноярск, ул. Партизана Железняка, 3г</p></bio><bio xml:lang="en"><p>PhD, MD (Medicine), Professor, Head, Clinical Department of Somatic and Mental Health of Children, </p><p>660022, Krasnoyarsk, Partizan Zheleznyak str., 3g</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Научно-исследовательский институт медицинских проблем Севера – обособленное подразделение ФГБНУ «Федеральный исследовательский центр Красноярский научный центр Сибирского отделения Российской академии наук»<country>Россия</country></aff><aff xml:lang="en">Research Institute of Medical Problems of the North, Krasnoyarsk Science Center, Siberian Branch, Russian Academy of Sciences<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>19</day><month>10</month><year>2021</year></pub-date><volume>23</volume><issue>4</issue><fpage>887</fpage><lpage>894</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Смольникова М.В., Горбачева Н.Н., Шубина М.В., Терещенко С.Ю., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Смольникова М.В., Горбачева Н.Н., Шубина М.В., Терещенко С.Ю.</copyright-holder><copyright-holder xml:lang="en">Smolnikova M.V., Gorbacheva N.N., Shubina M.V., Tereschenko S.Y.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/2434">https://www.mimmun.ru/mimmun/article/view/2434</self-uri><abstract><p>Изучение патогенеза бронхиальной астмы является актуальной проблемой в связи с ее высокой распространенностью и зачастую бесконтрольным развитием тяжелых форм, в том числе в детском возрасте. Первые признаки развития астмы обычно возникают в детстве, что приводит к ухудшению качества жизни пациента и ранней инвалидизации. Поскольку астма является генетически опосредованным процессом, предполагается, что тяжесть заболевания зависит от наличия определенного аллельного варианта в медиаторных (таких как цитокины) генах, участвующих в патогенезе БА. Целью данного исследования был поиск иммуногенетических маркеров тяжелого течения астмы у детей славянского происхождения, проживающих в г. Красноярск. Впервые с помощью метода мультиплексного анализа (xMAP) определены количественные показатели Th1/Th2/ Th17-цитокинового профиля у больных бронхиальной астмой (БА) детей с различной степенью тяжести заболевания, в зависимости от полиморфизма генов цитокинов. Изменения цитокинового фона у больных БА укладываются в концепцию о том, что при тяжелых формах астмы возрастает доля нейтрофильного эндотипа заболевания, осуществляющего свои функции посредством Th1 и Th17-лимфоцитов. Кроме этого, получены данные цитокинового профиля в зависимости от наличия сопутствующих острых респираторных инфекций: показан дисбаланс уровня цитокинов, с тенденцией сохранения защитных функций иммунной системы у больных в состоянии ремиссии. Получено распределение в генах цитокинов: аллельные варианты IL12В rs321220*G, IL13 rs1800925*С, IL31 rs7977932*C и IL33 rs7044343*T являются наиболее часто встречающимися в популяционной выборке г. Красноярска. Изучена вероятность ассоциации генотипов полиморфных генов цитокинов (IL12В, IL13, IL31, IL33) с состоянием иммунной системы при бронхиальной астме с различной степенью тяжести заболевания у детей: показана достоверная ассоциация генотипа TT IL12B rs3212220 с низкой концентрацией IL-12B. Полученные данные можно использовать в комплексе с полученными нами ранее иммуногенетическими маркерами тяжелой степени и неконтролируемого течения астмы у детей с целью персонифицированного прогноза характера заболевания. </p></abstract><trans-abstract xml:lang="en"><p>The study of the bronchial asthma pathogenesis is an urgent problem due to its high prevalence and often developing uncontrolled severe ashma, including in childhood. The first signs of asthma development tend to occur in childhood, which causes deterioration in the patient’s quality of life and early disability. Since BA is a genetically mediated process, the severity of the disease is assumed to depend on the presence of a specific allelic variant in the mediator (e.g. cytokines) genes involved in the BA pathogenesis. The aim of this study was to search for immunogenetic markers of severe asthma in Slavs children living in Krasnoyarsk city. The quantitative indicators of the Th1/Th2/Th17-cytokine profile in children with bronchial asthma (BA) with varying disease severity, depending on the polymorphism of cytokine genes, using the method of multiplex analysis (xMAP), were first determined. Changes in the cytokine background in BA patients fit into the concept that a percentage of neutrophilic endotype, which performs its functions through Th1 and Th17-lymphocytes in severe asthma, increases. In addition, the cytokine profile data depending on concomitant acute respiratory infections were obtained. There was an imbalance when analyzing the cytokine plasma level, with a tendency to maintain the protective functions of the immune system among patients in remission. Distribution of cytokine genes was obtained: allelic variants of IL12B rs321220*G, IL13 rs1800925*C, IL31 rs7977932*C and IL33 rs7044343*T are the most common in the population sampling from Krasnoyarsk. The probability of the genotype association of cytokine genes (IL12B, IL13, IL31, IL33) with the state of the immune system in bronchial asthma with varying disease severity in children was studied: a significant association of the TT genotype IL12B rs3212220 with a low concentration of IL-12B was presented. Our data obtained can be used along with the previously obtained immunogenetic markers of severe and uncontrolled asthma in children for patient-specific prognosis of the disease nature. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>бронхиальная астма</kwd><kwd>дети</kwd><kwd>цитокины</kwd><kwd>мультиплексный анализ</kwd><kwd>полиморфизм</kwd><kwd>тяжесть заболевания</kwd></kwd-group><kwd-group xml:lang="en"><kwd>bronchial asthma</kwd><kwd>child</kwd><kwd>cytokines</kwd><kwd>multiplex assay</kwd><kwd>polymorphism</kwd><kwd>disease severity</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Arsentieva N.A., Totolyan A.A. Methodological difficulties in determining the content of some cytokines in the peripheral blood of practically healthy individuals. Medical Immunology (Russia), 2018, Vol. 20, no. 5, pp. 763-774. (In Russ.) doi: 10.15789/1563-0625-2018-5-763-774</mixed-citation><mixed-citation xml:lang="en">Arsentieva N.A., Totolyan A.A. Methodological difficulties in determining the content of some cytokines in the peripheral blood of practically healthy individuals. Medical Immunology (Russia), 2018, Vol. 20, no. 5, pp. 763-774. (In Russ.) doi: 10.15789/1563-0625-2018-5-763-774</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Beghe B., Hall I.P., Parker S.G., Moffatt M.F., Wardlaw A., Connolly M.J., Fabbri L.M., Ruse C., Sayers I. Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease. Allergy, 2010, Vol. 65, no. 4, pp. 474-481.</mixed-citation><mixed-citation xml:lang="en">Beghe B., Hall I.P., Parker S.G., Moffatt M.F., Wardlaw A., Connolly M.J., Fabbri L.M., Ruse C., Sayers I. Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease. Allergy, 2010, Vol. 65, no. 4, pp. 474-481.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Bidwell J., Keen L., Gallageher G., Huizinga T., McDermott M.F., Oksenberg J., McNicholl J., Pociot F., Hardt C., D’Alfonso S. Cytokine gene polymorphism in human disease: on-line databases. Supplement 1. Genes Immun., 2001, Vol. 2, no. 2, pp. 61-70.</mixed-citation><mixed-citation xml:lang="en">Bidwell J., Keen L., Gallageher G., Huizinga T., McDermott M.F., Oksenberg J., McNicholl J., Pociot F., Hardt C., D’Alfonso S. Cytokine gene polymorphism in human disease: on-line databases. Supplement 1. Genes Immun., 2001, Vol. 2, no. 2, pp. 61-70.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bijanzadeh M., Mahesh P.A., Ramachandra N.B. An understanding of the genetic basis of asthma. Indian J. Med. Res., 2011, Vol. 134, no 2, pp. 149-161.</mixed-citation><mixed-citation xml:lang="en">Bijanzadeh M., Mahesh P.A., Ramachandra N.B. An understanding of the genetic basis of asthma. Indian J. Med. Res., 2011, Vol. 134, no 2, pp. 149-161.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cosmi L., Liotta F., Maggi E., Romagnani S., Annunziato F. Th17-cells: new players in asthma pathogenesis. Allergy, 2011, Vol. 66, no. 8, pp. 989-998.</mixed-citation><mixed-citation xml:lang="en">Cosmi L., Liotta F., Maggi E., Romagnani S., Annunziato F. Th17-cells: new players in asthma pathogenesis. Allergy, 2011, Vol. 66, no. 8, pp. 989-998.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Daneshmandi S., Pourfathollah A.A, Pourpak Z., Heidarnazhad H., Kalvanagh P.A. Cytokine gene polymorphism and asthma susceptibility, progress and control level. Mol. Biol. Rep., 2012, Vol. 39, no. 2, pp. 1845-1853.</mixed-citation><mixed-citation xml:lang="en">Daneshmandi S., Pourfathollah A.A, Pourpak Z., Heidarnazhad H., Kalvanagh P.A. Cytokine gene polymorphism and asthma susceptibility, progress and control level. Mol. Biol. Rep., 2012, Vol. 39, no. 2, pp. 1845-1853.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Drews A.C., Pizzichini M.M., Pizzichini E., Pereira M.U., Pitrez P.M., Jones M.H., Sly P.D., Stein R.T. Neutrophilic airway inflammation is a main feature of induced sputum in nonatopic asthmatic children. Allergy, 2009, Vol. 64, no. 11, pp. 1597-1601.</mixed-citation><mixed-citation xml:lang="en">Drews A.C., Pizzichini M.M., Pizzichini E., Pereira M.U., Pitrez P.M., Jones M.H., Sly P.D., Stein R.T. Neutrophilic airway inflammation is a main feature of induced sputum in nonatopic asthmatic children. Allergy, 2009, Vol. 64, no. 11, pp. 1597-1601.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Durrant D.M., Metzger D.W. Emerging roles of T helper subsets in the pathogenesis of asthma. Immunol. Invest., 2010, Vol. 39, no. 4-5, pp. 526-549.</mixed-citation><mixed-citation xml:lang="en">Durrant D.M., Metzger D.W. Emerging roles of T helper subsets in the pathogenesis of asthma. Immunol. Invest., 2010, Vol. 39, no. 4-5, pp. 526-549.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Grindebacke H., Wing K., Andersson A.C., Rak S., Rudin A. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergies during birch pollen season. Clin. Exp. Allergy, 2004, Vol. 34, no. 9, pp. 1364-1372.</mixed-citation><mixed-citation xml:lang="en">Grindebacke H., Wing K., Andersson A.C., Rak S., Rudin A. Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergies during birch pollen season. Clin. Exp. Allergy, 2004, Vol. 34, no. 9, pp. 1364-1372.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Iwakura Y., Nakae S., Saijo S., Ishigame H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol. Rev., 2008, Vol. 226, pp. 57-79.</mixed-citation><mixed-citation xml:lang="en">Iwakura Y., Nakae S., Saijo S., Ishigame H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol. Rev., 2008, Vol. 226, pp. 57-79.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kawaguchi M., Adachi M., Oda N., Kokubu F., Huang S-K. IL-17 cytokine family. Allergy Clin. Immunol., 2004, Vol. 114, no. 6, pp. 1265-1273.</mixed-citation><mixed-citation xml:lang="en">Kawaguchi M., Adachi M., Oda N., Kokubu F., Huang S-K. IL-17 cytokine family. Allergy Clin. Immunol., 2004, Vol. 114, no. 6, pp. 1265-1273.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ketlinsky S.A., Simbirtsev A.S. Cytokines. St. Petersburg: Folio, 2008, 552 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Ketlinsky S.A., Simbirtsev A.S. Cytokines. St. Petersburg: Folio, 2008, 552 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Nair R.P., Ruether A., Stuart P.E., Jenisch S., Tejasvi T., Hiremagalore R., Schreiber S., Kabelitz D., Lim H.W., Voorhees J.J., Christophers E., Elder J.T., Weichenthal M. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J. Invest. Dermatol., 2008, Vol. 128, no. 7, pp. 1653-1661.</mixed-citation><mixed-citation xml:lang="en">Nair R.P., Ruether A., Stuart P.E., Jenisch S., Tejasvi T., Hiremagalore R., Schreiber S., Kabelitz D., Lim H.W., Voorhees J.J., Christophers E., Elder J.T., Weichenthal M. Polymorphisms of the IL12B and IL23R genes are associated with psoriasis. J. Invest. Dermatol., 2008, Vol. 128, no. 7, pp. 1653-1661.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., Sekikawa K., Asano M., Iwakura Y. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity, 2002, Vol. 17, no. 3, pp. 375-387.</mixed-citation><mixed-citation xml:lang="en">Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., Sekikawa K., Asano M., Iwakura Y. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity, 2002, Vol. 17, no. 3, pp. 375-387.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Puzyrev V.P., Stepanov V.A. Pathological anatomy of the human genome. Novosibirsk: Nauka, 1997. 224 p. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Puzyrev V.P., Stepanov V.A. Pathological anatomy of the human genome. Novosibirsk: Nauka, 1997. 224 p. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Robinson D.S. The role of the T cell in asthma. J. Allergy Clin. Immunol., 2010, Vol. 126, no. 6, pp. 1081-1091.</mixed-citation><mixed-citation xml:lang="en">Robinson D.S. The role of the T cell in asthma. J. Allergy Clin. Immunol., 2010, Vol. 126, no. 6, pp. 1081-1091.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Spencer L.A., Melo R.C., Perez S.A., Bafford S.P., Dvorak A.M., Weller P.F. Cytokine receptor mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion. Proc. Natl Acad. Sci. USA, 2006, Vol. 103, no. 9, pp. 3333-3338.</mixed-citation><mixed-citation xml:lang="en">Spencer L.A., Melo R.C., Perez S.A., Bafford S.P., Dvorak A.M., Weller P.F. Cytokine receptor mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion. Proc. Natl Acad. Sci. USA, 2006, Vol. 103, no. 9, pp. 3333-3338.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Wang Y.H., Wills-Karp M. The potential role of interleukin-17 in severe asthma. Curr. Allergy Asthma Rep., 2011, Vol. 11, no 5, pp. 388-394.</mixed-citation><mixed-citation xml:lang="en">Wang Y.H., Wills-Karp M. The potential role of interleukin-17 in severe asthma. Curr. Allergy Asthma Rep., 2011, Vol. 11, no 5, pp. 388-394.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
